4//SEC Filing
Medytox Solutions, Inc. 4
Accession 0001019687-15-004111
CIK 0001374536operating
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 11:47 AM ET
Size
11.4 KB
Accession
0001019687-15-004111
Insider Transaction Report
Form 4
Lagan Seamus
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Options to Purchase Common Stock
2015-11-02−1,000,000→ 0 total(indirect: By LLC)Exercise: $10.00From: 2012-10-01Exp: 2022-12-31→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Common Stock
2015-11-02−1,030,000→ 0 total(indirect: By LLC) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02−1,000,000→ 0 total(indirect: By LLC)Exercise: $5.00From: 2012-10-01Exp: 2017-12-31→ Common Stock (1,000,000 underlying)
Alcimede LLC
10% Owner
Transactions
- Disposition to Issuer
Options to Purchase Common Stock
2015-11-02−1,000,000→ 0 total(indirect: By LLC)Exercise: $10.00From: 2012-10-01Exp: 2022-12-31→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02−1,000,000→ 0 total(indirect: By LLC)Exercise: $5.00From: 2012-10-01Exp: 2017-12-31→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Common Stock
2015-11-02−1,030,000→ 0 total(indirect: By LLC)
Footnotes (2)
- [F1]Disposed of pursuant to merger agreement among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub") and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.) in exchange for 421,927 shares of Rennova common stock.
- [F2]Cancelled pursuant to merger agreement and related transactions among Medytox, Merger Sub and Rennova.
Documents
Issuer
Medytox Solutions, Inc.
CIK 0001374536
Entity typeoperating
Related Parties
1- filerCIK 0001374536
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 11:47 AM ET
- Size
- 11.4 KB